Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved
OverviewProgramme: iPlacenta: A European Union Horizon 2020 innovative training network (ITN)
SEEK ID: https://fairdomhub.org/projects/275
Public web page: Not specified
Organisms: No Organisms specified
FAIRDOM PALs: No PALs for this Project
Project created: 27th Dec 2021
Related items
Projects: COVID-19 Disease Map, Molecular characterization and angiogenic properties of extracellular vesicles in healthy and preeclamptic amniotic fluid, Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved, Comparative Proteome Profile of Placental Sub-anatomical regions, The deregulated interplay of complement system and antioxidant activity as a driver of adverse pregnancy outcomes
Institutions: University of Rostock, Instituto de Investigación Sanitaria La Fe
https://orcid.org/0000-0002-0034-7755
The principal research aim of iPLACENTA is to improve our ability to study, model and visualise the placenta. This will contribute to developing diagnostic tests and therapies for pregnancy complications such as preeclampsia and intrauterine growth restriction (IUGR). Placental defects are thought to be the cause of many major pregnancy complications, such as preeclampsia and intra-uterine growth restriction. Preeclampsia affects between 5 and 8 out of every 100 pregnant women and claims the lives ...
Projects: Molecular characterization and angiogenic properties of extracellular vesicles in healthy and preeclamptic amniotic fluid, Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved, Comparative Proteome Profile of Placental Sub-anatomical regions, The deregulated interplay of complement system and antioxidant activity as a driver of adverse pregnancy outcomes
Web page: https://www.iplacenta.eu/
Description of PCR validation results expressed as 2 -ΔΔCt of miR 25-3p, miR 185-5p and miR 132-3p
Creator: Gabriela Loscalzo
Submitter: Gabriela Loscalzo
Description of PCR validation results expressed as 2 -ΔΔCt of miR 25-3p, miR 185-5p and miR 132-3p
Creator: Gabriela Loscalzo
Submitter: Gabriela Loscalzo
Description of PCR validation results expressed as 2 -ΔΔCt of miR 25-3p, miR 185-5p and miR 132-3p
Creator: Gabriela Loscalzo
Submitter: Gabriela Loscalzo
It is a description of the maternal clinical data, fetal Doppler ultrasound data and delivery data of both groups of cases (late-onset fetal growth restriction) and controls (normal growth).
Creator: Gabriela Loscalzo
Submitter: Gabriela Loscalzo
It is a description of the maternal clinical data, fetal Doppler ultrasound data and delivery data of both groups of cases (late-onset fetal growth restriction) and controls (normal growth).
Creator: Gabriela Loscalzo
Submitter: Gabriela Loscalzo
